Twenty‐five years of addressing cutting‐edge scientific, policy, and regulatory issues through collaboration: The Forum for Collaborative Research
Abstract Developing safe and effective drugs and other medical products is a complex and costly process. Drug development has been, historically, commonly competitive and uncollaborative, and this tendency toward a lack of interaction between stakeholders—the pharmaceutical industry, academia, regul...
Saved in:
| Main Authors: | Robin Schaefer, Alessi Ayvaz, Christopher R. Hoffman, Margot Yann, Zachary Rooney, Mitchell Leus, Shilpa Mitra, Veronica Miller, for the Forum for Collaborative Research |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-10-01
|
| Series: | Clinical and Translational Science |
| Online Access: | https://doi.org/10.1111/cts.70051 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising results of HIV prevention trials highlight the benefits of collaboration in global health: The perspective of the Forum HIV Recency Assay Working Group.
by: Robin Schaefer, et al.
Published: (2024-01-01) -
Pandemic and epidemic intelligence innovation forum: bridging gaps in epidemic intelligence through global collaboration
by: Barbara Tornimbene, et al.
Published: (2025-02-01) -
Downsizing Harshness Framework: Wage Cuts or Layoffs in a Collaborative Context?
by: Arney Einarsdottir, et al.
Published: (2025-07-01) -
Assessing the impact of virtual workplaces on collaboration and learning
by: Irene Sánchez Rodríguez, et al.
Published: (2025-06-01) -
Inclusively Designing for People in Human-Robot Collaboration.
by: Laurianne Sitbon, et al.
Published: (2024-06-01)